Ur Metser, MD, FRCPC

Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre
Affiliate Scientist, Techna Institute for the Advancement of Technology for Health (Techna)
Keywords: molecular imaging, magnetic resonance imaging (MRI), medical imaging, radiation therapy
  • Clinical applications of functional imaging in oncology
  • Fusion imaging: positron emission tomography, computed tomography, magnetic resonance imaging
  • Novel radiopharmaceuticals targeting tumors
  • Metabolic response assessment to therapy
18 F-Fluorodeoxyglucose positron-emission tomography for the investigation of malignancy in patients with suspected paraneoplastic neurologic syndromes and negative or indeterminate conventional imaging: a retrospective analysis of the Ontario PET...
Curr Oncol. 2019 Aug;26(4):e458-e465
Harlos C, Metser U, Poon R, MacCrostie P, Mason W
FDG-PET parameters predict for recurrence in anal cancer - results from a prospective, multicentre clinical trial.
Radiat Oncol. 2019 Aug 06;14(1):140
Jones MP, Hruby G, Metser U, Sridharan S, Capp A, Kumar M, Gallagher S, Rutherford N, Holder C, Oldmeadow C, Martin J
Repeatability and reproducibility of MRI-based radiomic features in cervical cancer.
Radiother Oncol. 2019 Mar 19;135:107-114
Fiset S, Welch ML, Weiss J, Pintilie M, Conway JL, Milosevic M, Fyles A, Traverso A, Jaffray D, Metser U, Xie J, Han K
Utility of 18F-FDG-PET/CT imaging in patients with recurrent gynecological malignancies prior to pelvic exenteration.
Int J Gynecol Cancer. 2019 Mar 28;:
Kim SR, Lee YY, Brar H, Albert A, Covens A, Metser U, May T
The contribution of multiparametric pelvic & whole body MR to interpretation of 18F-fluoromethylcholine or 68Ga-HBED-CC PSMA-11 PET/CT in patients with biochemical failure following radical prostatectomy.
J Nucl Med. 2019 Mar 22;:
Metser U, Chua SS, Ho B, Punwani S, Johnston E, Pouliot F, Tau N, Hawsawy A, Anconina R, Bauman G, Hicks RJ, Weickhardt A, Davis ID, Pond G, Scott A, Tunariu N, Sidhu H, Emmett LM
Applying Radiomics to Predict Pathology of Postchemotherapy Retroperitoneal Nodal Masses in Germ Cell Tumors.
JCO Clin Cancer Inform. 2018 Dec;(2):1-12
Lewin J, Dufort P, Halankar J, O'Malley M, Jewett MAS, Hamilton RJ, Gupta A, Lorenzo A, Traubici J, Nayan M, Leão R, Warde P, Chung P, Anson Cartwright L, Sweet J, Hansen AR, Metser U, Bedard PL
Effect of Positron Emission Tomography Imaging in Women With Locally Advanced Cervical Cancer: A Randomized Clinical Trial.
JAMA Netw Open. 2018 Sep 07;1(5):e182081
Elit LM, Fyles AW, Gu CS, Pond GR, D'Souza D, Samant R, Anthes M, Thomas G, Filion M, Arsenault J, Dayes I, Whelan TJ, Gulenchyn KY, Metser U, Dhamanaskar K, Levine MN
Effect of PET/CT on the Management and Outcomes of Participants with Hodgkin and Aggressive Non-Hodgkin Lymphoma: A Multicenter Registry.
Radiology. 2018 Dec 04;:181519
Metser U, Prica A, Hodgson DC, Mozuraitis M, Eberg M, Mak V, Green B, Singnurkar A, Dudebout J, MacCrostie P, Tau N, Mittmann N, Langer DL
A Prospective, Multi-site, International Comparison of F-18 fluoro-methyl-choline, multi-parametric magnetic resonance and Ga-68 HBED-CC (PSMA-11) in men with High-Risk Features and Biochemical Failure after Radical Prostatectomy: Clinical Performance...
J Nucl Med. 2018 Nov 15;:
Emmett L, Metser U, Bauman G, Hicks RJ, Weickhardt A, Davis ID, Punwani S, Pond GR, Chua SS, Ho B, Johnston E, Pouliot F, Scott A
Quantitative assessment of dynamic 18F-Fluoromethycholine PET and Dynamic Contrast Enhanced MRI in High Risk Prostate Cancer.
Br J Radiol. 2018 Nov 01;:20180568
Tau N, Berlin A, Yeung I, Halankar J, Murphy G, Jhaveri KS, Ghai S, Metser U

Pages


 
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre
Affiliate Scientist, Techna Institute for the Advancement of Technology for Health (Techna)

Associate Professor, Department of Medical Imaging, University of Toronto​